Related Experiment Video
Updated: May 1, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical
Nazar Mashtalir1, Salima Daou1, Haithem Barbour1
1Maisonneuve-Rosemont Hospital Research Center, Department of Medicine, University of Montréal, Montréal, QC H1T 2M4, Canada.
Abstract:
The tumor suppressor BAP1 interacts with chromatin-associated proteins and regulates cell proliferation, but its mechanism of action and regulation remain poorly defined. We show that the ubiquitin-conjugating enzyme UBE2O multi-monoubiquitinates the nuclear localization signal of BAP1, thereby inducing its cytoplasmic sequestration. This activity is counteracted by BAP1 autodeubiquitination through intramolecular interactions. Significantly, we identified cancer-derived BAP1 mutations that abrogate autodeubiquitination and promote its cytoplasmic retention, indicating that BAP1 autodeubiquitination ensures tumor suppression. The antagonistic relationship between UBE2O and BAP1 is also observed during adipogenesis, whereby UBE2O promotes differentiation and cytoplasmic localization of BAP1. Finally, we established a putative targeting consensus sequence of UBE2O and identified numerous chromatin remodeling factors as potential targets, several of which tested positive for UBE2O-mediated ubiquitination. Thus, UBE2O defines an atypical ubiquitin-signaling pathway that coordinates the function of BAP1 and establishes a paradigm for regulation of nuclear trafficking of chromatin-associated proteins.
Insights
The ubiquitin-conjugating enzyme UBE2O targets the tumor suppressor BAP1 for cytoplasmic sequestration, a process critical for cell proliferation and tumor suppression. Disrupting this balance through cancer mutations impairs BAP1 function.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor BAP1 (BRCA1-associated protein 1) plays a role in cell proliferation, but its regulatory mechanisms are not fully understood.
- Understanding how BAP1's function is controlled is crucial for cancer research and developing targeted therapies.
Purpose of the Study:
- To elucidate the mechanism by which the ubiquitin-conjugating enzyme UBE2O regulates BAP1.
- To investigate the role of BAP1 autodeubiquitination in tumor suppression and its disruption in cancer.
- To explore the broader implications of UBE2O in regulating chromatin-associated proteins and nuclear trafficking.
Main Methods:
- Investigated the interaction between UBE2O and BAP1 using biochemical assays.
- Analyzed the effect of UBE2O-mediated ubiquitination on BAP1 localization.
- Studied cancer-derived BAP1 mutations to assess their impact on autodeubiquitination and localization.
- Examined the role of UBE2O and BAP1 in adipogenesis.
- Identified UBE2O target sequences and validated ubiquitination of chromatin remodeling factors.
Main Results:
- UBE2O multi-monoubiquitinates BAP1's nuclear localization signal, causing cytoplasmic sequestration.
- BAP1 autodeubiquitination, through intramolecular interactions, counteracts UBE2O's effect.
- Cancer-associated BAP1 mutations impair autodeubiquitination, leading to cytoplasmic retention and loss of tumor suppression.
- UBE2O promotes adipogenesis and BAP1 cytoplasmic localization.
- UBE2O targets chromatin remodeling factors for ubiquitination, revealing a novel signaling pathway.
Conclusions:
- UBE2O regulates BAP1 nuclear trafficking via atypical ubiquitination, impacting cell proliferation and tumor suppression.
- BAP1 autodeubiquitination is essential for its tumor suppressor function, and its disruption in cancer contributes to disease progression.
- This study uncovers a novel ubiquitin-signaling pathway governing chromatin-associated protein function and nuclear transport.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Anaphase Promoting Complex
The Intrinsic Apoptotic Pathway

